<?xml version="1.0" encoding="UTF-8"?>
<collection>
<dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:invenio="http://invenio-software.org/elements/1.0" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd"><dc:identifier>doi:10.1016/j.ifset.2024.103745</dc:identifier><dc:language>eng</dc:language><dc:creator>Graikini, Dimitra</dc:creator><dc:creator>Alvarez-Sabatel, Saioa</dc:creator><dc:creator>Puértolas, Eduardo</dc:creator><dc:creator>Pérez, María Dolores</dc:creator><dc:creator>Sánchez, Lourdes</dc:creator><dc:title>Effect of ultra-high pressure homogenization on the antirotaviral activity of bovine milk whey</dc:title><dc:identifier>ART-2024-139307</dc:identifier><dc:description>In the present study, ultra-high pressure homogenization (UHPH, 100–250 MPa) was applied on bovine whey. The ability of UHPH-treated whey to neutralize the bovine rotavirus strain WC3 was evaluated in vitro using a model of human intestinal epithelium. Results showed that whey homogenized at 100 and 200 MPa inhibited the rotavirus infection in a dose-response way, exhibiting &gt;95% neutralization at 1.5 mg mL−1 protein concentration. However, after homogenization of whey at 250 MPa, a clear neutralization pattern could not be observed. This could be attributed to aggregation and/or denaturation of some bioactive proteins, as it has been evidenced in the electrophoretic profile of that sample. Interestingly, the fat fraction obtained from all UHPH-treated wheys, showed almost complete neutralization at 1 mg mL−1 protein concentration. Therefore, whey fractions could be used as functional ingredients in novel non-thermal processed products for the control of viral infections.
Industrial relevance
This study provides useful information to increase the commercial value of sweet, skimmed whey as a functional ingredient and its recognition as a natural source of antivirals. The use of emerging processing technologies, such as UHPH, could favor the preservation of certain bioactivity within the dairy by-product.</dc:description><dc:date>2024</dc:date><dc:source>http://zaguan.unizar.es/record/136275</dc:source><dc:doi>10.1016/j.ifset.2024.103745</dc:doi><dc:identifier>http://zaguan.unizar.es/record/136275</dc:identifier><dc:identifier>oai:zaguan.unizar.es:136275</dc:identifier><dc:relation>info:eu-repo/grantAgreement/ES/DGA/A20-23R</dc:relation><dc:relation>info:eu-repo/grantAgreement/EC/H2020/801586/EU/International Doctoral Programme for Talent Attraction to the Campus of International Excellence of the Ebro Valley/IberusTalent</dc:relation><dc:relation>This project has received funding from the European Union’s Horizon 2020 research and innovation program under grant agreement No H2020 801586-IberusTalent</dc:relation><dc:relation>info:eu-repo/grantAgreement/ES/MICINN/PID2022-139104OB-I00</dc:relation><dc:relation>info:eu-repo/grantAgreement/ES/MINECO/AGL2017-82987-R</dc:relation><dc:identifier.citation>INNOVATIVE FOOD SCIENCE &amp; EMERGING TECHNOLOGIES 96 (2024), 103745 [pp.]</dc:identifier.citation><dc:rights>by-nc-nd</dc:rights><dc:rights>https://creativecommons.org/licenses/by-nc-nd/4.0/deed.es</dc:rights><dc:rights>info:eu-repo/semantics/openAccess</dc:rights></dc:dc>

</collection>